Logo image of HBCP

HOME BANCORP INC (HBCP) Stock Fundamental Analysis

NASDAQ:HBCP - Nasdaq - US43689E1073 - Common Stock - Currency: USD

50.93  -1.36 (-2.6%)

After market: 50.93 0 (0%)

Fundamental Rating

5

Overall HBCP gets a fundamental rating of 5 out of 10. We evaluated HBCP against 393 industry peers in the Banks industry. HBCP has only an average score on both its financial health and profitability. HBCP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year HBCP was profitable.
HBCP had a positive operating cash flow in the past year.
In the past 5 years HBCP has always been profitable.
Each year in the past 5 years HBCP had a positive operating cash flow.
HBCP Yearly Net Income VS EBIT VS OCF VS FCFHBCP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

1.2 Ratios

With a decent Return On Assets value of 1.10%, HBCP is doing good in the industry, outperforming 73.79% of the companies in the same industry.
HBCP has a Return On Equity of 9.48%. This is in the better half of the industry: HBCP outperforms 62.09% of its industry peers.
Industry RankSector Rank
ROA 1.1%
ROE 9.48%
ROIC N/A
ROA(3y)1.11%
ROA(5y)1.19%
ROE(3y)10.16%
ROE(5y)10.4%
ROIC(3y)N/A
ROIC(5y)N/A
HBCP Yearly ROA, ROE, ROICHBCP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of HBCP (27.64%) is better than 74.30% of its industry peers.
In the last couple of years the Profit Margin of HBCP has remained more or less at the same level.
The Operating Margin and Gross Margin are not available for HBCP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.64%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.3%
PM growth 5Y-0.57%
GM growth 3YN/A
GM growth 5YN/A
HBCP Yearly Profit, Operating, Gross MarginsHBCP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

HBCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
HBCP has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HBCP has less shares outstanding
HBCP has a better debt/assets ratio than last year.
HBCP Yearly Shares OutstandingHBCP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
HBCP Yearly Total Debt VS Total AssetsHBCP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

The Debt to FCF ratio of HBCP is 1.36, which is an excellent value as it means it would take HBCP, only 1.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.36, HBCP is in the better half of the industry, outperforming 65.39% of the companies in the same industry.
A Debt/Equity ratio of 0.15 indicates that HBCP is not too dependend on debt financing.
HBCP's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. HBCP outperforms 57.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.36
Altman-Z N/A
ROIC/WACCN/A
WACC13.28%
HBCP Yearly LT Debt VS Equity VS FCFHBCP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBCP Yearly Current Assets VS Current LiabilitesHBCP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.51% over the past year.
Measured over the past years, HBCP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.40% on average per year.
Looking at the last year, HBCP shows a small growth in Revenue. The Revenue has grown by 7.45% in the last year.
HBCP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.08% yearly.
EPS 1Y (TTM)14.51%
EPS 3Y-7.61%
EPS 5Y8.4%
EPS Q2Q%42.16%
Revenue 1Y (TTM)7.45%
Revenue growth 3Y4.77%
Revenue growth 5Y6.08%
Sales Q2Q%13.47%

3.2 Future

Based on estimates for the next years, HBCP will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.70% on average per year.
Based on estimates for the next years, HBCP will show a small growth in Revenue. The Revenue will grow by 7.64% on average per year.
EPS Next Y15.23%
EPS Next 2Y10.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.46%
Revenue Next 2Y7.64%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HBCP Yearly Revenue VS EstimatesHBCP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
HBCP Yearly EPS VS EstimatesHBCP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.78 indicates a reasonable valuation of HBCP.
HBCP's Price/Earnings ratio is a bit cheaper when compared to the industry. HBCP is cheaper than 76.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of HBCP to the average of the S&P500 Index (26.82), we can say HBCP is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.13, the valuation of HBCP can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HBCP indicates a somewhat cheap valuation: HBCP is cheaper than 61.07% of the companies listed in the same industry.
HBCP is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.78
Fwd PE 9.13
HBCP Price Earnings VS Forward Price EarningsHBCP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HBCP is valued a bit cheaper than 68.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.97
EV/EBITDA N/A
HBCP Per share dataHBCP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.64
PEG (5Y)1.16
EPS Next 2Y10.7%
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

HBCP has a Yearly Dividend Yield of 2.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.48, HBCP is paying slightly less dividend.
HBCP's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of HBCP has a limited annual growth rate of 3.70%.
HBCP has been paying a dividend for at least 10 years, so it has a reliable track record.
HBCP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.7%
Div Incr Years10
Div Non Decr Years10
HBCP Yearly Dividends per shareHBCP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

21.83% of the earnings are spent on dividend by HBCP. This is a low number and sustainable payout ratio.
HBCP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.83%
EPS Next 2Y10.7%
EPS Next 3YN/A
HBCP Yearly Income VS Free CF VS DividendHBCP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HBCP Dividend Payout.HBCP Dividend Payout, showing the Payout Ratio.HBCP Dividend Payout.PayoutRetained Earnings

More info and screens

HOME BANCORP INC

NASDAQ:HBCP (8/1/2025, 8:00:02 PM)

After market: 50.93 0 (0%)

50.93

-1.36 (-2.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-15 2025-10-15/amc
Inst Owners48.8%
Inst Owner Change-1.18%
Ins Owners5.26%
Ins Owner Change0.83%
Market Cap397.76M
Analysts78
Price Target55.72 (9.41%)
Short Float %0.69%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend1.01
Dividend Growth(5Y)3.7%
DP21.83%
Div Incr Years10
Div Non Decr Years10
Ex-Date08-04 2025-08-04 (0.29)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.17%
Min EPS beat(2)6.87%
Max EPS beat(2)17.48%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)2.04%
Max EPS beat(4)17.48%
EPS beat(8)8
Avg EPS beat(8)11.09%
EPS beat(12)11
Avg EPS beat(12)9.22%
EPS beat(16)14
Avg EPS beat(16)10.37%
Revenue beat(2)2
Avg Revenue beat(2)1.88%
Min Revenue beat(2)0.73%
Max Revenue beat(2)3.03%
Revenue beat(4)4
Avg Revenue beat(4)1.49%
Min Revenue beat(4)0.73%
Max Revenue beat(4)3.03%
Revenue beat(8)4
Avg Revenue beat(8)-0.1%
Revenue beat(12)8
Avg Revenue beat(12)3.77%
Revenue beat(16)12
Avg Revenue beat(16)6.42%
PT rev (1m)0%
PT rev (3m)1.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.57%
EPS NY rev (1m)0%
EPS NY rev (3m)8.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.23%
Valuation
Industry RankSector Rank
PE 9.78
Fwd PE 9.13
P/S 2.87
P/FCF 8.97
P/OCF 7.79
P/B 0.99
P/tB 1.25
EV/EBITDA N/A
EPS(TTM)5.21
EY10.23%
EPS(NY)5.58
Fwd EY10.95%
FCF(TTM)5.68
FCFY11.15%
OCF(TTM)6.54
OCFY12.83%
SpS17.72
BVpS51.65
TBVpS40.78
PEG (NY)0.64
PEG (5Y)1.16
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 9.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.64%
GM N/A
FCFM 32.06%
ROA(3y)1.11%
ROA(5y)1.19%
ROE(3y)10.16%
ROE(5y)10.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.3%
PM growth 5Y-0.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.36
Debt/EBITDA N/A
Cap/Depr 193.96%
Cap/Sales 4.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 116%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC13.28%
ROIC/WACCN/A
Cap/Depr(3y)83.57%
Cap/Depr(5y)79.54%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.14%
Profit Quality(3y)120.9%
Profit Quality(5y)132.26%
High Growth Momentum
Growth
EPS 1Y (TTM)14.51%
EPS 3Y-7.61%
EPS 5Y8.4%
EPS Q2Q%42.16%
EPS Next Y15.23%
EPS Next 2Y10.7%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.45%
Revenue growth 3Y4.77%
Revenue growth 5Y6.08%
Sales Q2Q%13.47%
Revenue Next Year11.46%
Revenue Next 2Y7.64%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.15%
FCF growth 3Y-5.69%
FCF growth 5Y2.18%
OCF growth 1Y-14.27%
OCF growth 3Y-4.37%
OCF growth 5Y2.09%